// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Understanding the onset of Leber's Hereditary Optic Neuropathy

Rustum Karanjia - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Cardiovascular comorbidity in Leber’s hereditary optic neuropathy mtDNA 11778

Starleen Frousiakis - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Collagen-like-peptide nano-implants as stem cell loaded substitutes to human cornea transplantation

Michel Haagdorens - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

DE-074

A Randomized Clinical Trial of SLT vs ALT in Patients Who Have Already Received 360 Degrees of SLT-The Canadian Laser Study Trial Network.

William Hodge - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Optical Coherence Tomography (OCT) Neural Canal Direction, Obliqueness and Minimum Cross-sectional Area in a Normal Population

Seung Woo Hong - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultrastable gold nanoparticles as a new drug vector for glaucoma therapy

Florence Masse - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

The inhibition of Nogo-A promotes vascular and neuronal recovery in a mouse model of proliferative retinopathy

Sandrine Joly - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Real-world outcomes of Aflibercept treatment for chronic diabetic macular edema in Bevacizumab non-responders in a Canadian setting

Ali Salimi - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Aflibercept

Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) in Routine Clinical Practice

John D Pitcher - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Trends in radiation practices for female ocular oncologists in North America

Sona Shah - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

The epidemiology and clinical features of patients with both ocular and cutaneous melanomas.

Myriam MacDonald - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Besifloxacin Ophthalmic Suspension in Patients With Bacterial Keratitis: A Prospective, Randomized Clinical Study

Fatma Zaguia - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Besifloxacin

Retinal Ganglion Cell Numbers In Early Post-Natal AP-2β Neural Crest Cell Knockout Mice

Anthony Saraco - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

stannous fluoride

Pericytes promote capillary constriction leading to impaired retinal blood flow and microvascular dysfunction during ischemic damage.

Deborah Villafranca-Baughman - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Neurodevelopmental Outcomes in Infants Treated for Retinopathy of Prematurity: bevacizumab versus laser

Maram Isaac - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Bevacizumab

5-years longitudinal assessment of ocular manifestations in Fabry patients

Langis Michaud - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Herpes Zoster Vaccine and Risk of Aneterior Segment Complications

Mahyar Etminan - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Herpes zoster vaccine

Quantification of proteoglycan 4 (PRG4) / lubricin in normal and Sjögren Syndrome human tears

Tannin A Schmidt - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Contribution of the feeder layer type to the preservation of stem cells in cultured human corneal epithelial cells

Gaatan Le-Bel - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months

Mark E Pennesi - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved